DGX
QUEST DIAGNOSTICS INC
+0.99 (+0.40%)248.07USD296K成交股數27.4B市值26.3本益比(近四季)2.4股價營收比+10.2%營收年增(近四季)2026-10-20下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 5 · 8.3M · 3 |
| 其中 10b5-1 計畫賣出 | 5 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 11.9M |
| 近 180 天 淨額 | −11.9M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 09-03 | Davis J. E. | CEO and President | S 公開市場賣出(10b5-1) | 10.0K | 242.72 | 2.4M | 122K | SEC |
| 2026-08-28 | 08-31 | PREVOZNIK MICHAEL E | SVP & General Counsel | G 贈與 | 1.0K | – | – | 36.6K | SEC |
| 2026-08-28 | 08-31 | PREVOZNIK MICHAEL E | SVP & General Counsel | M 選擇權執行 | 22.7K | 112.17 | 2.5M | 60.2K | SEC |
| 2026-08-28 | 08-31 | PREVOZNIK MICHAEL E | SVP & General Counsel | S 公開市場賣出(10b5-1) | 16.0K | 242.88 | 3.9M | 44.2K | SEC |
| 2026-08-28 | 08-31 | PREVOZNIK MICHAEL E | SVP & General Counsel | S 公開市場賣出(10b5-1) | 430 | 244.51 | 105K | 37.6K | SEC |
| 2026-08-28 | 08-31 | PREVOZNIK MICHAEL E | SVP & General Counsel | S 公開市場賣出(10b5-1) | 6.2K | 243.63 | 1.5M | 38.0K | SEC |
| 2026-07-28 | 07-29 | DELANEY MARK E | SVP & Chief Commercial Officer | S 公開市場賣出(10b5-1) | 1.6K | 235.18 | 376K | 10.3K | SEC |
| 2026-07-22 | 07-27 | SAMAD SAM | Executive Vice President & CFO | A 獲配股票 | 102 | 206.81 | 21K | 33.5K | SEC |
| 2026-07-22 | 07-27 | Gregg Vicky B | Director | A 獲配股票 | 72 | 206.81 | 15K | 18.4K | SEC |
| 2026-06-04 | 06-08 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M 選擇權執行 | 4.8K | 121.81 | 588K | 21.7K | SEC |
| 2026-06-04 | 06-08 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S 公開市場賣出(10b5-1) | 8.1K | 200.00 | 1.6M | 13.5K | SEC |
| 2026-06-04 | 06-08 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M 選擇權執行 | 3.3K | 127.73 | 424K | 16.8K | SEC |
| 2026-06-01 | 06-02 | Davis J. E. | CEO and President | S 公開市場賣出(10b5-1) | 10.0K | 194.14 | 1.9M | 132K | SEC |
| 2026-05-20 | 05-21 | PFEIFFER GARY M | Director | A 獲配股票 | 1.1K | – | – | 31.0K | SEC |
| 2026-05-20 | 05-21 | MAIN TIMOTHY L | Director | A 獲配股票 | 1.1K | – | – | 27.4K | SEC |
| 2026-05-20 | 05-21 | Gregg Vicky B | Director | A 獲配股票 | 1.1K | – | – | 18.3K | SEC |
| 2026-05-20 | 05-21 | WENTWORTH TIMOTHY C | Director | A 獲配股票 | 1.1K | – | – | 1.4K | SEC |
| 2026-05-20 | 05-21 | Doi Tracey | Director | A 獲配股票 | 1.1K | – | – | 7.7K | SEC |
| 2026-05-20 | 05-21 | MORRISON DENISE M | Director | A 獲配股票 | 1.1K | – | – | 11.9K | SEC |
| 2026-05-20 | 05-21 | CARTER ROBERT B | Director | A 獲配股票 | 1.1K | – | – | 3.9K | SEC |
| 2026-05-20 | 05-21 | Diaz Luis | Director | A 獲配股票 | 1.1K | – | – | 5.2K | SEC |
| 2026-05-20 | 05-21 | Lassiter Wright III | Director | A 獲配股票 | 1.1K | – | – | 10.3K | SEC |
| 2026-05-20 | 05-21 | RING TIMOTHY M | Director | A 獲配股票 | 1.1K | – | – | 31.1K | SEC |
| 2026-04-20 | 04-24 | SAMAD SAM | Executive Vice President & CFO | A 獲配股票 | 108 | 194.70 | 21K | 33.4K | SEC |
| 2026-04-20 | 04-24 | Gregg Vicky B | Director | A 獲配股票 | 68 | 194.70 | 13K | 17.2K | SEC |
| 2026-03-09 | 03-11 | WENTWORTH TIMOTHY C | Director | A 獲配股票 | 215 | – | – | 215 | SEC |
| 2026-03-05 | 03-06 | Plewman Patrick | SVP for Diagnostic Services | S 公開市場賣出(10b5-1) | 2.9K | 206.21 | 589K | 15.2K | SEC |
| 2026-03-05 | 03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | S 公開市場賣出(10b5-1) | 3.9K | 206.21 | 800K | 37.6K | SEC |
| 2026-03-05 | 03-06 | Doherty Catherine T. | EVP, Regional Businesses | S 公開市場賣出(10b5-1) | 5.6K | 206.21 | 1.1M | 67.1K | SEC |
| 2026-03-04 | 03-06 | Plewman Patrick | SVP for Diagnostic Services | A 獲配股票 | 5.7K | 204.86 | 1.2M | 20.9K | SEC |
| 2026-03-04 | 03-06 | Deppe Michael J | SVP, Corp. Controller & CAO | F 繳稅扣股 | 750 | 204.86 | 154K | 35.2K | SEC |
| 2026-03-04 | 03-06 | Deppe Michael J | SVP, Corp. Controller & CAO | A 獲配股票 | 1.5K | 204.86 | 302K | 35.9K | SEC |
| 2026-03-04 | 03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S 公開市場賣出 | 2.6K | 204.86 | 538K | 13.4K | SEC |
| 2026-03-04 | 03-06 | SAMAD SAM | Executive Vice President & CFO | A 獲配股票 | 13.9K | 204.86 | 2.9M | 41.0K | SEC |
| 2026-03-04 | 03-06 | DELANEY MARK E | SVP & Chief Commercial Officer | F 繳稅扣股 | 2.3K | 204.86 | 477K | 11.9K | SEC |
| 2026-03-04 | 03-06 | SAMAD SAM | Executive Vice President & CFO | F 繳稅扣股 | 7.7K | 204.86 | 1.6M | 33.3K | SEC |
| 2026-03-04 | 03-06 | Plewman Patrick | SVP for Diagnostic Services | F 繳稅扣股 | 2.8K | 204.86 | 579K | 18.1K | SEC |
| 2026-03-04 | 03-06 | Doherty Catherine T. | EVP, Regional Businesses | F 繳稅扣股 | 5.8K | 204.86 | 1.2M | 72.7K | SEC |
| 2026-03-04 | 03-06 | Doherty Catherine T. | EVP, Regional Businesses | A 獲配股票 | 11.4K | 204.86 | 2.3M | 78.5K | SEC |
| 2026-03-04 | 03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A 獲配股票 | 6.2K | 204.86 | 1.3M | 16.1K | SEC |
| 2026-03-04 | 03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | A 獲配股票 | 7.2K | 204.86 | 1.5M | 44.8K | SEC |
| 2026-03-04 | 03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | F 繳稅扣股 | 3.4K | 204.86 | 687K | 41.4K | SEC |
| 2026-03-04 | 03-06 | DELANEY MARK E | SVP & Chief Commercial Officer | A 獲配股票 | 5.7K | 204.86 | 1.2M | 14.2K | SEC |
| 2026-03-04 | 03-06 | Davis J. E. | CEO and President | A 獲配股票 | 51.7K | 204.86 | 10.6M | 169K | SEC |
| 2026-03-04 | 03-06 | Davis J. E. | CEO and President | F 繳稅扣股 | 26.4K | 204.86 | 5.4M | 142K | SEC |
| 2026-03-03 | 03-04 | Doherty Catherine T. | EVP, Regional Businesses | S 公開市場賣出(10b5-1) | 632 | 207.73 | 131K | 67.1K | SEC |
| 2026-03-03 | 03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | S 公開市場賣出(10b5-1) | 526 | 207.73 | 109K | 37.6K | SEC |
| 2026-03-03 | 03-04 | Plewman Patrick | SVP for Diagnostic Services | S 公開市場賣出(10b5-1) | 410 | 207.73 | 85K | 15.2K | SEC |
| 2026-03-02 | 03-04 | Deppe Michael J | SVP, Corp. Controller & CAO | F 繳稅扣股 | 88 | 204.86 | 18K | 34.5K | SEC |
| 2026-03-02 | 03-04 | Doherty Catherine T. | EVP, Regional Businesses | F 繳稅扣股 | 648 | 204.86 | 133K | 67.8K | SEC |
| 2026-03-02 | 03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F 繳稅扣股 | 205 | 204.86 | 42K | 9.9K | SEC |
| 2026-03-02 | 03-04 | SAMAD SAM | Executive Vice President & CFO | F 繳稅扣股 | 869 | 204.86 | 178K | 27.0K | SEC |
| 2026-03-02 | 03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | F 繳稅扣股 | 288 | 204.86 | 59K | 38.1K | SEC |
| 2026-03-02 | 03-04 | Davis J. E. | CEO and President | S 公開市場賣出(10b5-1) | 10.0K | 212.52 | 2.1M | 117K | SEC |
| 2026-03-02 | 03-04 | Davis J. E. | CEO and President | F 繳稅扣股 | 3.0K | 204.86 | 608K | 127K | SEC |
| 2026-03-02 | 03-04 | Plewman Patrick | SVP for Diagnostic Services | F 繳稅扣股 | 230 | 204.86 | 47K | 15.6K | SEC |
| 2026-03-02 | 03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | F 繳稅扣股 | 188 | 204.86 | 39K | 8.5K | SEC |
| 2026-02-19 | 02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | S 公開市場賣出(10b5-1) | 1.1K | 204.83 | 228K | 38.4K | SEC |
| 2026-02-19 | 02-20 | Doherty Catherine T. | EVP, Regional Businesses | S 公開市場賣出(10b5-1) | 1.4K | 204.83 | 294K | 68.4K | SEC |
| 2026-02-19 | 02-20 | Plewman Patrick | SVP for Diagnostic Services | S 公開市場賣出(10b5-1) | 958 | 204.83 | 196K | 15.8K | SEC |
| 2026-02-18 | 02-20 | Plewman Patrick | SVP for Diagnostic Services | F 繳稅扣股 | 244 | 210.01 | 51K | 17.1K | SEC |
| 2026-02-18 | 02-20 | Plewman Patrick | SVP for Diagnostic Services | A 獲配股票 | 2.0K | – | – | 17.3K | SEC |
| 2026-02-18 | 02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | F 繳稅扣股 | 347 | 206.99 | 72K | 39.5K | SEC |
| 2026-02-18 | 02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | F 繳稅扣股 | 301 | 210.01 | 63K | 39.8K | SEC |
| 2026-02-18 | 02-20 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F 繳稅扣股 | 252 | 210.01 | 53K | 8.2K | SEC |
| 2026-02-18 | 02-20 | Deppe Michael J | SVP, Corp. Controller & CAO | F 繳稅扣股 | 83 | 210.01 | 17K | 34.7K | SEC |
| 2026-02-18 | 02-20 | Deppe Michael J | SVP, Corp. Controller & CAO | A 獲配股票 | 366 | – | – | 34.7K | SEC |
| 2026-02-18 | 02-20 | Davis J. E. | CEO and President | F 繳稅扣股 | 3.8K | 206.99 | 784K | 130K | SEC |
| 2026-02-18 | 02-20 | SAMAD SAM | Executive Vice President & CFO | F 繳稅扣股 | 855 | 210.01 | 180K | 28.9K | SEC |
| 2026-02-18 | 02-20 | SAMAD SAM | Executive Vice President & CFO | A 獲配股票 | 4.0K | – | – | 29.7K | SEC |
| 2026-02-18 | 02-20 | Doherty Catherine T. | EVP, Regional Businesses | A 獲配股票 | 2.9K | – | – | 71.0K | SEC |
| 2026-02-18 | 02-20 | Davis J. E. | CEO and President | F 繳稅扣股 | 2.4K | 210.01 | 503K | 134K | SEC |
| 2026-02-18 | 02-20 | Davis J. E. | CEO and President | A 獲配股票 | 15.9K | – | – | 136K | SEC |
| 2026-02-18 | 02-20 | SAMAD SAM | Executive Vice President & CFO | F 繳稅扣股 | 1.0K | 206.99 | 209K | 27.8K | SEC |
| 2026-02-18 | 02-20 | Doherty Catherine T. | EVP, Regional Businesses | F 繳稅扣股 | 728 | 206.99 | 151K | 69.8K | SEC |
| 2026-02-18 | 02-20 | Doherty Catherine T. | EVP, Regional Businesses | F 繳稅扣股 | 433 | 210.01 | 91K | 70.6K | SEC |
| 2026-02-18 | 02-20 | Plewman Patrick | SVP for Diagnostic Services | F 繳稅扣股 | 293 | 206.99 | 61K | 16.8K | SEC |
| 2026-02-18 | 02-20 | Deppe Michael J | SVP, Corp. Controller & CAO | F 繳稅扣股 | 99 | 206.99 | 20K | 34.6K | SEC |
| 2026-02-18 | 02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | A 獲配股票 | 2.0K | – | – | 40.1K | SEC |
| 2026-02-18 | 02-20 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F 繳稅扣股 | 259 | 206.99 | 54K | 7.9K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 9.3M | 2.0B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.2M | 1.5B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.1M | 1.3B | 新進 | 新進 |
| STATE STREET CORP | 5.5M | 1.2B | 新進 | 新進 |
| Boston Partners | 4.7M | 1.0B | 新進 | 新進 |
| JPMORGAN CHASE & CO | 3.5M | 749M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1M | 663M | 新進 | 新進 |
| MORGAN STANLEY | 2.5M | 522M | 新進 | 新進 |
| EdgePoint Investment Group Inc. | 2.2M | 476M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.0M | 421M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.9M | 410M | 新進 | 新進 |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1.9M | 400M | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 1.8M | 371M | 新進 | 新進 |
| Davis Selected Advisers | 1.6M | 330M | 新進 | 新進 |
| VICTORY CAPITAL MANAGEMENT INC | 1.6M | 329M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 1.4M | 298M | 新進 | 新進 |
| FMR LLC | 1.4M | 296M | 新進 | 新進 |
| Invesco Ltd. | 1.4M | 292M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.1M | 239M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 983K | 208M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 942K | 200M | 新進 | 新進 |
| UBS Group AG | 889K | 188M | 新進 | 新進 |
| AMERICAN CENTURY COMPANIES INC | 818K | 173M | 新進 | 新進 |
| M&G PLC | 796K | 169M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 774K | 164M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 1,107 +38 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1107 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 105M · 95.1% |
| 合計季末市值 | 20.4B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.4M |
|---|---|
| 與上期比 | +3.7% |
| 佔流通股數 | 3.12% |
| 日均成交量 | 894K |
| 回補天數 | 3.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.4M | +3.7% | 3.12% | 894K | 3.9 |
| 2026-08-14 | 3.3M | -9.8% | 3.01% | 712K | 4.7 |
| 2026-07-31 | 3.7M | +5.0% | 3.34% | 1.3M | 2.7 |
| 2026-07-15 | 3.5M | -6.0% | 3.18% | 824K | 4.3 |
| 2026-06-30 | 3.7M | +9.2% | 3.38% | 971K | 3.8 |
| 2026-06-15 | 3.4M | -0.3% | 3.10% | 803K | 4.3 |
| 2026-05-29 | 3.4M | -7.7% | 3.11% | 822K | 4.2 |
| 2026-05-15 | 3.7M | +9.6% | 3.37% | 745K | 5.0 |
| 2026-04-30 | 3.4M | -4.6% | 3.07% | 1.3M | 2.6 |
| 2026-04-15 | 3.6M | -14.9% | 3.22% | 772K | 4.6 |
| 2026-03-31 | 4.2M | +7.8% | 3.78% | 937K | 4.5 |
| 2026-03-13 | 3.9M | -0.0% | 3.51% | 745K | 5.2 |
| 2026-02-27 | 3.9M | -18.8% | 3.51% | 845K | 4.6 |
| 2026-02-13 | 4.8M | -18.1% | 4.32% | 1.5M | 3.3 |
| 2026-01-30 | 5.8M | +1.8% | 5.28% | 1.0M | 5.6 |
| 2026-01-15 | 5.7M | -2.2% | 5.18% | 969K | 5.9 |
| 2025-12-31 | 5.8M | +38.4% | 5.30% | 874K | 6.7 |
| 2025-12-15 | 4.2M | -1.7% | 3.83% | 988K | 4.3 |
| 2025-11-28 | 4.3M | +0.1% | 3.90% | 1.2M | 3.5 |
| 2025-11-14 | 4.3M | -6.9% | 3.89% | 1.1M | 3.9 |
| 2025-10-31 | 4.6M | +16.8% | 4.18% | 1.3M | 3.5 |
| 2025-10-15 | 3.9M | -8.8% | 3.58% | 980K | 4.0 |
| 2025-09-30 | 4.3M | -2.1% | 3.92% | 757K | 5.7 |
| 2025-09-15 | 4.4M | +4.1% | 4.01% | 616K | 7.2 |
| 2025-08-29 | 4.2M | +5.4% | 3.85% | 826K | 5.1 |
| 2025-08-15 | 4.0M | -14.9% | 3.65% | 845K | 4.8 |